Important Safety Information for Repaglinide and clopidogrel. New Contraindication for Concomitant Use

Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction. The concomitant use of repaglinide and clopidogrel is now contraindicated. 

Important Safety Information for Repaglinide and clopidogrel. New Contraindication for Concomitant Use